加拿大的心血管介入裝置市場：2011年 是由出版商Millennium Research Group在2010年09月所出版的。
這份英文市場調查報告書價格從美金5995起跳。
本報告，針對加拿大的心血管介入裝置市場的概要、冠狀動脈支架、PTCA氣球擴張導管、通路裝置的市場概要與競爭分析等，由下列摘要形式闡述。
報告摘要
方法論
第1章 加拿大的心血管介入裝置市場
- 市場概要
- 冠狀動脈疾病概要
- 治療概要
- 病患別的治療
- 加拿大的醫療制度
- 市場分析
- 競爭分析
第2章 冠狀動脈支架市場
- 市場概要
- 市場分析
- 處置
- 市場預測
- 市場促進因子與阻礙因子
- 塗藥支架市場的促進因子與阻礙因子
- 裸金屬支架市場的促進因子與阻礙因子
- 競爭分析
第3章 PTCA氣球擴張導管市場
第4章 通路裝置市場
第5章 心血管介入裝置市場的競爭分析
- 競爭分析
- 競爭環境
- 市佔率
- 競爭企業
- Abbott Vascular
- BIOTRONIK
- Boston Scientific
- Cordis
- Medtronic
- 其他
附錄
Abstract
In 2010, the coronary stent segment continued to represent the majority of
interventional cardiology (IC) device revenues in Canada due to the widespread
use of stents in percutaneous coronary interventions (PCIs) and their
relatively high price compared to other IC devices. Over the forecast period,
coronary stent revenues will continue to expand, supported by the growing
adoption of premium-priced drug-eluting stents (DES) over bare-metal stents
(BMS). This will be spurred by diminishing concerns over the safety of DES due
to the release of positive clinical data and by continued improvements to
deliverability and ease-of-use of next-generation devices. Although DES
procedure volumes will grow significantly, the average selling prices (ASPs)
of DES will decrease moderately through 2015 from competitive pricing
pressures. To attract customers, companies in the market will engage in
aggressive pricing strategies, such as offering discounts on high-volume
purchases or product bundles of their premium-priced coronary stents with
percutaneous transluminal coronary angioplasty (PTCA) balloon catheters and
accessories. While these practices will encourage greater unit sales, ASP
growth will be restricted, thereby curbing revenue expansion. Furthermore,
provincial and territorial governments are banding together to form a
pan-Canadian purchasing alliance to negotiate lower costs for drugs and
medical equipment from manufacturers, thus also limiting the Canadian IC
device market through 2015. Despite these limitations, climbing PCI volumes -
as a result of the increasing coronary artery disease patient population -
will support demand for IC devices, allowing the Canadian market to grow at a
modest compound annual growth rate through 2015.
METHODOLOGY
RESEARCH METHODOLOGY
This report uses a number of methodologies to gather and present data and
analysis. At the outset, a large survey of secondary sources is conducted.
These sources act as the basis for the primary research stage, which builds
and enhances the quantitative and qualitative attributes of the early research.
Secondary sources include
- Government sources:
- Canadian Institute for Health Information
- Statistics Canada
- Interventional cardiology (IC) device companies:
- Annual reports, product brochures, corporate profiles, etc.
- Internal databases and reports:
- Previous reports on similar/related sources
- General Internet searches, medical literature, and newspaper/magazine
searches:
- Identifying various centers of specialization and articles that might
provide leads for primary research
The secondary research stage builds the foundation for the primary research.
The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the
information gathered during the secondary research stage to determine its
utility based on the specific requirements of this report. Each piece of
information is either discarded or marked as high- or low-priority and then
organized appropriately as determined by the structure and sectioning of the
report.
Step 2: At this stage, early assumptions are formed as to the
implications of the information for the various IC device market segments.
These assumptions are then used to determine hypotheses using both inductive
and deductive approaches. On the quantitative front, these hypotheses result
in full historical and projected market data sets (market sizes - unit sales,
average selling prices [ASPs], and revenues - as well as market shares).
Step 3: At this stage, the research is in position for its most
important primary phase - expert interviews. Throughout the secondary research
phase, industry and medical experts are identified. These experts are then
contacted by telephone and asked to participate in interviews on recent trends
and developments in the industry. Interviews are either conducted at the time
of the initial call or scheduled at the convenience of the expert. Interview
questions are tailored to the expertise of each particular interviewee,
although in most cases, the most important questions are asked of all experts.
The questions are largely based on the assumptions and hypotheses developed in
Step 2, which are then augmented, discarded, or adjusted based on the views
and positions put forth. Attempts are made, whenever possible, to cross-check
the views of various experts against each other and to reach positions of
consensus on issues and market numbers.
In addition, a sample of relevant physicians is also interviewed. Physicians
are asked to comment on various issues/trends, both in their own practice and
in the overall market. The responses provided are then used to strengthen or
augment the assumptions and hypotheses developed during the primary research
phase.
Step 4: The final stage of primary research involves individual and
group analysis by Millennium Research Group. All research results are assessed
and cross-checked thoroughly to determine their validity, relevance, and
weight. From this process, qualitative conclusions are reached and data points
finalized.
FORECAST METHODOLOGY
In addition to Steps 1 through 4 as outlined above, the following
“bottom-up” methodology is used to develop forecast assumptions
for the report.
A comprehensive breakdown of various IC procedures is prepared using data from
several sources, including professional associations, government statistics,
and private research/media sources. Industry experts and practitioners are
consulted to ensure accuracy and verify observed trends. As a cross-check,
total industry revenues available through annual reports and other sources are
compared against modeled industry revenues.
Using the best estimates of industry experts, practitioners, private
research/media sources, and inhouse experts, year-by-year growth rates and
ASPs are applied individually to each subcategory to derive forecasts. These
estimates are cross-checked by industry experts (marketing managers, product
managers, CEOs, etc.) and further refined.
Overall findings are compared against market and procedure forecasts published
by other sources to ensure reasonable estimates.
Table of Contents
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
METHODOLOGY
1.0 CANADIAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET
- 1.1 Market Overview
- 1.2 Coronary Artery Disease Overview
- 1.3 Treatment Overview
- 1.3.1 Medical Management
- 1.3.2 Coronary Artery Bypass Graft Surgery
- 1.3.3 Percutaneous Coronary Intervention
- 1.3.3.1 Stenting
- 1.3.3.2 Percutaneous Transluminal Balloon Angioplasty
- 1.3.4 Intravascular Imaging Catheters and Pressure Guidewires
- 1.3.5 Femoral versus Radial Approach for PCI
- 1.4 Treatment of Unique CAD Patient Subsets
- 1.4.1 Treatment of Diabetic Patients
- 1.4.2 Treatment of Patients with Bifurcated Lesions
- 1.5 Canadian Health Care System
- 1.5.1 Health Care Funding
- 1.5.2 Medical Device Purchasing Trends
- 1.5.3 Demographics
- 1.6 Market Analysis
- 1.6.1 Key Report Updates
- 1.6.2 Procedures
- 1.6.3 Market Forecast
- 1.6.4 Market Drivers and Limiters
- 1.7 Competitive Analysis
2.0 CORONARY STENT MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Procedures
- 2.2.1.1 Clinical Trial Summaries
- 2.2.2 Market Forecast
- 2.2.2.1 Drug-Eluting Stent Market
- Physician Feedback on Bioresorbable Polymers and Bioresorbable Stents
- 2.2.2.2 Bare-Metal Stent Market
- 2.2.3 Market Drivers and Limiters
- 2.2.3.1 Drug-Eluting Stent Market Drivers and Limiters
- 2.2.3.2 Bare-Metal Stent Market Drivers and Limiters
- 2.3 Competitive Analysis
3.0 PTCA BALLOON CATHETER MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Procedures
- 3.2.2 Market Forecast
- Physician Feedback on Drug-Eluting Balloons
- 3.2.3 Market Drivers and Limiters
- 3.3 Competitive Analysis
4.0 ACCESSORY DEVICE MARKET
- 4.1 Market Overview
- 4.2 Market Analysis
- 4.2.1 Procedures
- 4.2.2 Market Forecast
- 4.2.2.1 PTCA Guidewire Market
- 4.2.2.2 Diagnostic Catheter Market
- 4.2.2.3 PTCA Guiding Catheter Market
- 4.2.2.4 Introducer Sheath Market
- 4.2.3 Market Drivers and Limiters
- 4.3 Competitive Analysis
5.0 INTERVENTIONAL CARDIOLOGY DEVICE MARKET COMPETITIVE ANALYSIS
- 5.1 Competitive Analysis
- 5.1.1 Competitive Landscape
- 5.1.2 Market Shares
- 5.1.3 Competitor Discussions (in Alphabetical Order)
- Abbott Vascular
- BIOTRONIK
- Boston Scientific
- Cordis
- Medtronic
- Other
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: SUPPLEMENTAL FIGURES
LIST OF FIGURES AND TABLES
TABLE OF CONTENTS
LIST OF FIGURES AND TABLES
EXECUTIVE SUMMARY
- Figure 1: IC Device Market, Canada (US$), 2009 - 2015
- Figure 2: Coronary Stent Procedures, by Segment, as a % of Total, Canada,
2009 - 2015
- Figure 3: PTCA Balloon Catheter Procedures, by Type, Canada, 2009 - 2015
- Figure 4: Accessory Device Market, Canada (US$), 2009 - 2015
- Table 1: Companies Mentioned in This Report
METHODOLOGY
- Table 2: Average Currency Exchange Rates, 2010
1.0 CANADIAN INTERVENTIONAL CARDIOLOGY DEVICE MARKET
- Figure 5: IC Device Market, Canada (US$), 2009 - 2015
- Figure 6: CAD Treatment Options
- Table 3: Key Report Updates, 2011
- Figure 7: IC Procedures, by Type, Canada, 2009 - 2015
- Figure 8: PCIs, by Type, Canada, 2009 - 2015
- Table 4: IC Procedures, by Type, Canada, 2009 - 2015
- Table 5: PCIs, by Type, Canada, 2009 - 2015
- Table 6: IC Device Market, by Segment, Canada (US$), 2009 - 2015
- Table 7: IC Device Market, by Segment, Canada (CA$), 2009 - 2015
- Table 8: Drivers of the IC Device Market, Canada
- Table 9: Limiters of the IC Device Market, Canada
- Figure 9: Leading Competitors in the IC Device Market, as a % of Total,
Canada, 2010
- Table 10: Leading Competitors in the IC Device Market, by Segment, as a %
of Total, Canada, 2010
2.0 CORONARY STENT MARKET
- Figure 10: Coronary Stent Market, by Segment, Canada (US$), 2009 - 2015
- Figure 11: Coronary Stent Procedures, by Segment, Canada, 2009 - 2015
- Table 11: Coronary Stent Procedures, by Type, Canada, 2009 - 2015
- Table 12: Coronary Stent Procedures and Units, by Segment, Canada, 2009 -
2015
- Table 13: Coronary Stent Procedure and Unit Growth, by Segment, Canada,
2010 - 2015
- Table 14: Coronary Stent Procedures and Units, by Segment, as a % of
Total, Canada, 2009 - 2015
- Table 15: Select Clinical Trial Summaries, 2010
- Table 16: Coronary Stent Market, by Segment, Canada (US$), 2009 - 2015
- Table 17: Coronary Stent Market, by Segment, Canada (CA$), 2009 - 2015
- Table 18: Coronary Stent Market Growth, by Segment, Canada, 2010 - 2015
- Table 19: Coronary Stent Market, by Segment, as a % of Total, Canada, 2009
- 2015
- Table 20: Drivers of the DES Market, Canada
- Table 21: Limiters of the DES Market, Canada
- Table 22: Drivers of the BMS Market, Canada
- Table 23: Limiters of the BMS Market, Canada
- Table 24: Leading Competitors in the Coronary Stent Market, by Segment, as
a % of Total, Canada, 2010
3.0 PTCA BALLOON CATHETER MARKET
- Figure 12: PTCA Balloon Catheter Market, by Segment, Canada (US$), 2009 -
2015
- Figure 13: PTCA Balloon Catheter Procedures, by Type, Canada, 2009 - 2015
- Table 25: PTCA Balloon Catheter Procedures, by Type, Canada, 2009 - 2015
- Table 26: PTCA Balloon Catheter Procedures and Units, Canada, 2009 - 2015
- Table 27: PTCA Balloon Catheter Market, by Segment, Canada (US$), 2009 -
2015
- Table 28: PTCA Balloon Catheter Market, by Segment, Canada (CA$), 2009 -
2015
- Table 29: PTCA Balloon Catheter Market Growth, by Segment, Canada, 2010 -
2015
- Table 30: PTCA Balloon Catheter Market, by Segment, as a % of Total,
Canada, 2009 - 2015
- Table 31: Drivers of the PTCA Balloon Catheter Market, Canada
- Table 32: Limiters of the PTCA Balloon Catheter Market, Canada
- Table 33: Leading Competitors in the PTCA Balloon Catheter Market, by
Segment, as a % of Total, Canada, 2010
4.0 ACCESSORY DEVICE MARKET
- Figure 14: Accessory Device Market, by Segment, Canada (US$), 2009 - 2015
- Table 34: IC Procedures, by Type, Canada, 2009 - 2015
- Table 35: Accessory Device Market, by Segment, Canada (US$), 2009 - 2015
- Table 36: Accessory Device Market, by Segment, Canada (CA$), 2009 - 2015
- Table 37: PTCA Guidewire Market, by Segment, Canada (US$), 2009 - 2015
- Table 38: PTCA Guidewire Market, by Segment, Canada (CA$), 2009 - 2015
- Table 39: PTCA Guidewire Market Growth, by Segment, Canada, 2010 - 2015
- Table 40: PTCA Guidewire Market, by Segment, as a % of Total, Canada, 2009
- 2015
- Table 41: Diagnostic Catheter Market, Canada (US$ and CA$), 2009 - 2015
- Table 42: PTCA Guiding Catheter Market, Canada (US$ and CA$), 2009 - 2015
- Table 43: Introducer Sheath Market, Canada (US$ and CA$), 2009 - 2015
- Table 44: Drivers of the Accessory Device Market, Canada
- Table 45: Limiters of the Accessory Device Market, Canada
- Table 46: Leading Competitors in the Accessory Device Market, by Segment,
as a % of Total, Canada, 2010
5.0 INTERVENTIONAL CARDIOLOGY DEVICE MARKET COMPETITIVE ANALYSIS
- Table 47: Leading Competitors in the IC Device Market, by Segment, as a %
of Total, Canada, 2010
APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
APPENDIX B: SUPPLEMENTAL FIGURES
- Figure 15: IC Device Market, Canada (US$), 2009 - 2015 (Detailed Format)
- Figure 16: Coronary Stent Procedures, by Segment, as a % of Total, Canada,
2009 - 2015 (Detailed Format)
- Figure 17: PTCA Balloon Catheter Procedures, by Type, Canada, 2009 - 2015
(Detailed Format)
- Figure 18: Accessory Device Market, Canada (US$), 2009 - 2015 (Detailed
Format)
加拿大市場塗藥血管支架(DES)價格下降的壓力增強
2010年11月01日
Global Information, Inc.已開始銷售加拿大市場調查公司Millennium Research Group所發行的報告書「Canadian Markets for Interventional Cardiology Devices 2011 (加拿大的心血管介入裝置市場：2011年)」
一般認為在2010年銷售額將達到5,500萬美元的加拿大心血管介入性治療機器市場，塗藥血管支架（Drug Eluting Stents：DES）是收益最大的領域。另一方面，該市場是充滿流動性、經爭激烈的世界，少數大企業面臨激烈爭奪市佔率的狀況。加拿大的醫療制度因存在許多壁壘，治療機器製造商無法輕易進入。
一般認為加拿大接受治療機器的重要原因之一是價格，而且與該國醫療制度的成立有關。加拿大為使全民都能接受醫療，由政府決定醫療機關購買治療機器使用的預算。因此幾乎沒有醫院和醫療機關使用最尖端、而且價格昂貴的機器。因為購買高價的機器，而且提供全部患者治療實有困難。因此，在加拿大心血管介入性治療機器市場銷售額已達極限，各家製造商對進入該市場或投入新產品的事裹足不前。製造商方面的看法是該市場成本效率不太高。
MRG的分析者Adrienne Ma先生敘述：「一般認為以往金屬支架的處理件數減少，反之，DES的處理件數到2015年為止將持續增加。因為聆聽進行介入性治療的心臟內科醫生的話，各家製造商為維持與醫院的交易關係或獲得新的契約，在打算提高市佔率之爭中，以及降低價格的壓力亦增強，故DES的價格大幅下降。在加拿大公共醫療制度規定有限的預算中，醫療機關能實施使更多患者使用DES的治療，可說是價格下跌的正面效果。」。
|
